4/30/2013 6:53:20 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company will be presenting an overview of the use of sd-rxRNAs® in the eye and highlighting specifically RXi’s work in the areas of retinoblastoma and proliferative vitreoretinopathy at the 2013 ARVO ( Association for Research in Vision and Ophthalmology) Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by